Philips extends advanced automation capabilities on its EPIQ CVx cardiology ultrasound platform, making accurate exams faster...
June 20 2019 - 9:00AM
Philips extends advanced automation capabilities on its EPIQ CVx
cardiology ultrasound platform, making accurate exams faster and
easier to conduct
June 20, 2019
- With new release, clinicians can reduce the number of touches
of the system by 21% per exam, equivalent to more than 400 exams
each year
- Platform provides advanced automation for right ventricle
volumes and ejection fraction measurements in as little as 15
seconds, speeding exam times
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today announced new advanced automation capabilities on
its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems. With Release
5.0, both the EPIQ CVx and EPIQ CVxi now include automated
applications for 2D assessment of the heart, as well as robust 3D
right ventricle volume and ejection fraction measurements, making
accurate exams faster and easier to conduct [1]. Together, the new
applications provide clinicians with the means to confidently
evaluate the heart’s function, increasing diagnostic confidence for
patients with pulmonary hypertension, congenital heart disease,
coronary disease and heart failure.
“The complexity of cardiac exams can be a barrier to accessing
high quality care. Philips is addressing this by leveraging
Artificial Intelligence to make echo exams easier, faster and more
reproducible,” said David Handler, General Manager of Cardiac
Ultrasound at Philips. “By incorporating advanced automation, there
is less variability between scans, leading to accurate treatment
decisions which benefits patients. The new release of EPIQ CVx is a
major step forward, reducing the number of touches of the system by
21% in each exam, which is equivalent to more than 400 exams each
year [2].”
The AutoStrain LV application uses advanced
Automatic View Recognition technology to identify the different
views of the heart, providing exceptional visualization and
analysis of left ventricular function – extremely important
diagnostic information for patients at risk of developing
cardiovascular disease. Also available are AutoStrain
LA and AutoStrain RV, applications which
automate the measurement of left atrial and right ventricular
longitudinal strain respectively. By creating reliable and
reproducible strain measurements for the left ventricle, left
atrium and right ventricle, the AutoStrain LV, LA and RV
applications support clinicians treating patients with atrial
fibrillation, arrhythmia and other complex heart conditions.
The 3D Auto RV application segments, identifies
the borders of and aligns the views of the right ventricle,
enabling clinicians to carry out the quantification and check the
measurements in as little as 15 seconds [3]. These new applications
expand on the advanced automation applications already available on
the EPIQ CVx platform, including Dynamic
HeartModel, which provides a clear vision of the heart’s
chambers and how well they are pumping blood – specifically on the
left side, where heart failure often begins. A recent study of
Dynamic HeartModel published in the European Heart Journal –
Cardiovascular Imaging concluded that ‘the automated algorithm can
quickly measure dynamic left ventricle and left atrial volumes and
accurately analyze ejection/filling parameters’ [4].
The new release also adds diagnostic capabilities to the EPIC
CVxi. Tailored for use in the interventional lab, the system can
now also be used in the echo lab.
Advanced automation makes echo more accessible to a
growing patient baseBeyond monitoring overall heart
function, new medical fields such as cardio-oncology are using
echocardiography to better assess heart health during chemotherapy,
which can damage the heart if the dosage is not closely monitored.
Cardio-oncology has increased the global demand for
echocardiography as clinicians need to perform a deep analysis on
cardiac images throughout the patient’s treatment, ensuring
measurements are consistent from one exam to the next so that the
results can be reliably compared.
Philips will unveil EPIQ CVx Release 5.0 alongside its full
suite of solutions for diagnosis and interventional guidance during
the annual meeting of the American Society of Echo (ASE), taking
place June 21-25 in Portland, Oregon. Follow the #ASE2019
conversation on @PhilipsLiveFrom throughout the event and visit
Philips on booth #300. More information about the Release 5.0 is
available here.
[1] The Philips CVx and CVxi 5.0 Diagnostic ultrasound systems
are available for sale globally. The AutoStrain LV, LA, RV
applications and the Dynamic Heart Model application are CE marked
and FDA cleared and available for sale in Europe and in the USA.
The AI enabled 3D AutoRV application, designed using a Machine
Learning-based algorithm, is CE marked and FDA 510(k) pending, and
is therefore available for sale in Europe but is not available for
sale in the USA.[2] Based on eight scans per day over 48 weeks.[3]
Based on internal test results.[4] European Heart Journal –
Cardiovascular Imaging, “Machine learning based automated dynamic
quantification of left heart chambers volumes,” October 9,
2018.
For further information, please contact:
Mark GrovesPhilips Group Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.com Twitter: @mark_groves
Sarah HaegerPhilips UltrasoundTel: +1 206-920-8726Email:
sarah.haeger@philips.com Twitter: @sarahhaeger
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips' generated 2018 sales of EUR 18.1 billion
and employs approximately 77,000 employees with sales and services
in more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips_EPIQ_CVx_R5
- Image_showing_AutoStrain_LV_application
- Image_showing_3D_Auto_RV_application
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024